378 results on '"Dobesh, Paul P."'
Search Results
2. Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta‐analysis
3. The Impact of Eliminating Backward Navigation on Computerized Examination Scores and Completion Time
4. Dual Antiplatelet Therapy for Long-term Secondary Prevention of Atherosclerotic Cardiovascular Events
5. Comment on the 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults
6. Selatogrel: A Novel Subcutaneous P2Y12 Inhibitor
7. Betrixaban: Safely Reducing Venous Thromboembolic Events with Extended Prophylaxis
8. Reply to “Letter to Dobesh et al. on lower mortality with andexanet alfa in factor Xa inhibitor–related major bleeding”
9. Antithrombotic Therapy with Transcatheter Aortic Valve Replacement
10. Renal Function and Direct Oral Anticoagulant Treatment for Venous Thromboembolism
11. Renal Function Considerations for Stroke Prevention in Atrial Fibrillation
12. Pharmacology of Oral Anticoagulants
13. List of Contributors
14. The PARTHENON Clinical Development Program: the Role of Ticagrelor in Patients with Atherothrombotic Disease
15. Periprocedural Management of Direct Oral Anticoagulants Surrounding Cardioversion and Invasive Electrophysiological Procedures
16. Comment on the 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults.
17. Prospective Observational Evaluation of Predatory Journals in Critical Care Pharmacy Practice: Defining Characteristics Associated With Receiving Unsolicited Invitations to Publish.
18. Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism
19. Direct Oral Anticoagulants for the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: Understanding Differences and Similarities
20. When a Pharmacist Health Assessment Simulation Becomes a Real Patient-Provider Experience
21. New Oral Anticoagulants for the Treatment of Venous Thromboembolism: Understanding Differences and Similarities
22. Clinical Use of Rivaroxaban: Pharmacokinetic and Pharmacodynamic Rationale for Dosing Regimens in Different Indications
23. Measuring or Monitoring of Novel Anticoagulants: Which Laboratory Test to Request?
24. Prospective Observational Evaluation of Predatory Journals in Critical Care Pharmacy Practice: Defining Characteristics Associated With Receiving Unsolicited Invitations to Publish
25. When a Pharmacist Health Assessment Simulation Becomes a Real Patient-Provider Experience
26. Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety
27. Statins role in the prevention and treatment of sepsis
28. Prevalence of CYP2C19 variant alleles and pharmacodynamic variability of aspirin and clopidogrel in Native Americans
29. Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial
30. Direct Oral Anticoagulants in the Treatment of Venous Thromboembolism: Use in Patients with Advanced Renal Impairment, Obesity, or Other Weight-Related Special Populations
31. Real-world management of oral factor Xa inhibitor-related bleeds with reversal or replacement agents including andexanet alfa and four-factor prothrombin complex concentrate: a multicenter study
32. Prevalence of CYP2C19 variant alleles and pharmacodynamic variability of aspirin and clopidogrel in American Indians.: 163E.
33. Role of the Pharmacist in Achieving Performance Measures to Improve the Prevention and Treatment of Venous Thromboembolism
34. Key Articles and Guidelines in the Management of Acute Coronary Syndrome and in Percutaneous Coronary Intervention: 2012 Update
35. 266. Reducing heart failure readmissions: a multidisciplinary approach.
36. 159. Reduction in toll-like receptor-4 (tlr-4) on blood mononuclear cells after 3 weeks of rosuvastatin treatment in healthy male subjects.
37. 22E. Impact of a high-fat meal on assessment of clopidogrelinduced platelet inhibition in healthy subjects.
38. Key Articles and Guidelines in the Management of Peripheral Arterial Disease
39. Chapter 2 - Pharmacology of Oral Anticoagulants
40. Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID‐19
41. 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
42. Value of Conducting Pharmacy Residency Training—The Organizational Perspective
43. Antidotes for reversal of direct oral anticoagulants
44. Clopidogrel versus Prasugrel: Times Are Changing, but Not for Everyone
45. Key Articles and Guidelines in the Treatment of Venous Thromboembolism
46. Pharmacokinetics and Pharmacodynamics of Prasugrel, a Thienopyridine P2Y12 Inhibitor
47. Economic Burden of Venous Thromboembolism in Hospitalized Patients
48. Reduction in Mortality Associated with Statin Therapy in Patients with Severe Sepsis
49. Pharmacologic Therapy for Intermittent Claudication
50. Key Articles and Guidelines for the Prevention of Venous Thromboembolism
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.